Desvenlafaxine

FDA Drug Profile — Desvenlafaxine

Desvenlafaxine is listed in the FDA National Drug Code directory with 29 NDC codes, marketed under brand name including Desvenlafaxine. Available dosage forms: tablet, extended release, tablet, film coated, extended release, powder.

Drug details

Generic Name
Desvenlafaxine
Brand Names
Desvenlafaxine
Application Number
ANDA210014
Sponsor
Bryant Ranch Prepack
NDC Codes
29
Dosage Forms
TABLET, EXTENDED RELEASE, TABLET, FILM COATED, EXTENDED RELEASE, POWDER
Routes
ORAL
Active Ingredients
DESVENLAFAXINE SUCCINATE, DESVENLAFAXINE

Indications and Usage

1 INDICATIONS AND USAGE Desvenlafaxine extended-release tablets are indicated for the treatment of adults with major depressive disorder (MDD) [see Clinical Studies (14) ]. Desvenlafaxine Extended-Release Tablets are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with major depressive disorder (MDD) ( 1 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.